Loading...
Federal health officials announced Monday a $230 million deal to expand the use of a non-prescription at-home COVID-19 test. The Australia-based Ellume tests, which the FDA authorized for use in December, send results to users' smartphones within 15 minutes. |
|
Loading...
Loading...